MX2020004048A - Formas cristalinas de lenalidomida. - Google Patents
Formas cristalinas de lenalidomida.Info
- Publication number
- MX2020004048A MX2020004048A MX2020004048A MX2020004048A MX2020004048A MX 2020004048 A MX2020004048 A MX 2020004048A MX 2020004048 A MX2020004048 A MX 2020004048A MX 2020004048 A MX2020004048 A MX 2020004048A MX 2020004048 A MX2020004048 A MX 2020004048A
- Authority
- MX
- Mexico
- Prior art keywords
- lenalidomide
- crystalline forms
- crystalline
- forms
- empty
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención proporciona co-cristales novedosos de lenalidomida. La presente invención particularmente proporciona co-cristales novedosos de lenalidomida con resorcinol, metilparabeno y sacarina. La presente invención también proporciona los procesos para la producción de co-cristales de lenalidomida con resorcinol, metilparabeno y sacarina. La presente invención proporciona además procesos para la preparación de lenalidomida anhidra cristalina forma IV.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201741034364 | 2017-09-27 | ||
PCT/IB2018/057500 WO2019064222A1 (en) | 2017-09-27 | 2018-09-27 | CRYSTALLINE FORMS OF LENALIDOMIDE |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020004048A true MX2020004048A (es) | 2020-07-20 |
Family
ID=65901039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020004048A MX2020004048A (es) | 2017-09-27 | 2018-09-27 | Formas cristalinas de lenalidomida. |
Country Status (10)
Country | Link |
---|---|
US (2) | US11203585B2 (es) |
EP (1) | EP3687987A4 (es) |
JP (1) | JP2020535192A (es) |
KR (1) | KR20200092945A (es) |
AU (1) | AU2018343244A1 (es) |
BR (1) | BR112020006051A2 (es) |
CA (1) | CA3076986A1 (es) |
MX (1) | MX2020004048A (es) |
RU (1) | RU2020114885A (es) |
WO (1) | WO2019064222A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4196111A4 (en) * | 2020-08-14 | 2024-10-09 | Board Of Regents The Univ Of Texas System | METHOD FOR THE PRODUCTION OF PHARMACEUTICAL CO-CRYSTALS FOR ADDITIVE MANUFACTURING |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8946265B2 (en) * | 2009-03-02 | 2015-02-03 | Generics [Uk] Limited | Process for the preparation of lenalidomide |
WO2012127493A1 (en) * | 2011-03-23 | 2012-09-27 | Hetero Research Foundation | Polymorphs of lenalidomide |
CA2842316A1 (en) * | 2011-07-19 | 2013-01-24 | Amplio Pharma, Llc | Urea cocrystal of 3-(4-amin0-1-0x0-1,3 dihydro-isoindol-2-yl)piperidine-2,6-dione |
US9808450B2 (en) * | 2013-03-26 | 2017-11-07 | Celgene Corporation | Solid forms comprising 3-(4-amino-1-OXO-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof |
US9695146B2 (en) * | 2013-03-26 | 2017-07-04 | Celgene Corporation | Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof |
WO2016026785A1 (en) * | 2014-08-19 | 2016-02-25 | Synthon B.V. | Process for making crystalline form a of lenalidomide |
-
2018
- 2018-09-27 JP JP2020517936A patent/JP2020535192A/ja active Pending
- 2018-09-27 AU AU2018343244A patent/AU2018343244A1/en not_active Abandoned
- 2018-09-27 KR KR1020207012195A patent/KR20200092945A/ko not_active Application Discontinuation
- 2018-09-27 EP EP18863240.0A patent/EP3687987A4/en not_active Withdrawn
- 2018-09-27 CA CA3076986A patent/CA3076986A1/en not_active Abandoned
- 2018-09-27 BR BR112020006051-8A patent/BR112020006051A2/pt not_active Application Discontinuation
- 2018-09-27 RU RU2020114885A patent/RU2020114885A/ru unknown
- 2018-09-27 WO PCT/IB2018/057500 patent/WO2019064222A1/en unknown
- 2018-09-27 MX MX2020004048A patent/MX2020004048A/es unknown
-
2020
- 2020-03-27 US US16/832,112 patent/US11203585B2/en active Active
-
2021
- 2021-02-03 US US17/166,724 patent/US12098136B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
RU2020114885A (ru) | 2021-10-27 |
US11203585B2 (en) | 2021-12-21 |
US12098136B2 (en) | 2024-09-24 |
WO2019064222A1 (en) | 2019-04-04 |
EP3687987A1 (en) | 2020-08-05 |
US20210163442A1 (en) | 2021-06-03 |
CA3076986A1 (en) | 2019-04-04 |
AU2018343244A1 (en) | 2020-05-14 |
EP3687987A4 (en) | 2021-03-24 |
JP2020535192A (ja) | 2020-12-03 |
KR20200092945A (ko) | 2020-08-04 |
BR112020006051A2 (pt) | 2020-10-06 |
AU2018343244A2 (en) | 2020-06-04 |
US20200347027A1 (en) | 2020-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020003425A (es) | Tratamiento de trastornos inflamatorios. | |
MX2020004287A (es) | Procesamiento de biomasa. | |
IL269196A (en) | New inhibitors | |
GEP20227403B (en) | Compounds | |
MX2020003421A (es) | Metodos para la administracion de ciertos inhibidores del transportador vesicular de monoamina 2 (vmat2). | |
MX2020003760A (es) | Formulaciones de niraparib. | |
MX2020003706A (es) | Aminoimidazopiridazinas como inhibidores de cinasa. | |
MX2020004424A (es) | Formulacion aerosolizable. | |
MX2020003754A (es) | Metodo de formacion de elementos de microimagen. | |
IN2015DE00625A (es) | ||
LT3599836T (lt) | Tiektuvas | |
MX2020003617A (es) | Dispositivo de preparacion de cables. | |
MX2020004662A (es) | Ajuste planificado del contorno mediante especificaciones correspondientes. | |
GB2587987B (en) | Host-biome interactions | |
ZA201907529B (en) | Feeder | |
MX2020003578A (es) | Sal de edaravone. | |
MX2020004245A (es) | Estabilizador mejorado para poliamidas. | |
MX2020004272A (es) | Cartucho configurado para formar una parte de una pezonera y una pezonera. | |
MX2020004048A (es) | Formas cristalinas de lenalidomida. | |
MX2020003440A (es) | Red de seguridad. | |
MX2018009818A (es) | Formulacion y elaboracion de una pasta alimenticia con harina de trigo y hongo comestible. | |
MX2018009437A (es) | Sistema de prevención de perdida de dispositivos electrónicos móviles en tiempo real. | |
MX2020004664A (es) | Dispositivo generador de humo mejorado. | |
MX2020003539A (es) | Dispositivo de impulso. | |
MX2020003703A (es) | Composiciones de sabor. |